TGL WHAAAAAAAT! Alerts, thoughts, discussion. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jim Bishop who started this subject	4/16/2001 9:41:58 AM
From: SSP	of 150070

UTHR - List Stock news, Thursday April 12, 5:40 pm Eastern Time United Therapeutics, FDA agree to delay on Remodulin NEW YORK, April 12 (Reuters) - Drug developer United Therapeutics Inc. (NasdaqNM:UTHR - news) said on Thursday it had agreed with U.S. regulators to extend by 90 days the review of its Remodulin drug for pulmonary arterial hypertension. The company said it had agreed with the U.S. Food and Drug Administration to delay the decision on the drug so that the company could submit additional data in support of its new drug application. United Therapeutics said the delay would alter its previously stated revenues projections, which the firm would revise when the FDA makes a decision on the drug. The hypertension drug was undergoing priority review, meaning that the FDA would have likely reached a decision on approval within six months rather than the normal 12 months. Shares of United Therapeutics rose 55 cents, or 3.83 percent, to $14.90 on the Nasdaq on Thursday ahead of the news.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next